OptimizeRx Corporation
OPRX
$7.77
$0.628.67%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -75.81% | -24.83% | -28.36% | -53.57% | -31.09% |
| Total Depreciation and Amortization | 111.45% | 97.40% | 51.58% | 18.74% | 8.03% |
| Total Amortization of Deferred Charges | 860.63% | 554.84% | 766.88% | -- | -143.81% |
| Total Other Non-Cash Items | 63.18% | 25.18% | 25.75% | 44.41% | 11.68% |
| Change in Net Operating Assets | -266.75% | -1,289.57% | -1,190.81% | -492.54% | -530.55% |
| Cash from Operations | -185.98% | -149.44% | -177.61% | -167.95% | -72.05% |
| Capital Expenditure | -2.03% | -30.14% | 5.45% | -7.78% | 4.10% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -4,047.37% | -4,047.37% | 100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 405.64% | 198.22% | 198.23% | 198.31% | 52.98% |
| Cash from Investing | -47.76% | 49.83% | 59.87% | 56.45% | 55.21% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -91.15% | -95.88% | -85.85% | -85.00% | -97.53% |
| Repurchase of Common Stock | 95.20% | 97.27% | 60.73% | 60.24% | -21.62% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 200.00% | -- | -- | -- | 93.69% |
| Cash from Financing | 321.32% | 226.61% | 243.29% | 248.91% | -47.41% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 119.76% | 106.64% | 98.26% | 93.45% | 28.18% |
